Background. Studies on biopsy-proven renal disease in the elderly (age ≥65 years) are extremely limited in China. The aim of this study was to examine the spectrum of renal diseases and their clinical presentations in elderly patients undergoing renal biopsy. Methods. All native renal biopsies (n = 851) performed in patients aged ≥65 years from January 2003 to December 2012 were retrospectively analyzed. The results were compared with a control group of 28 574 patients aged 18-64 years undergoing renal biopsy over the same period. Results. These 851 patients included 549 males and 302 females. Primary glomerular diseases (53.94%) occurred more frequently than secondary glomerular diseases (36.49%). The clinical manifestations were nephrotic syndrome (NS) in 29.49% of the patients, chronic renal failure in 24.68%, proteinuria and hematuria in 13.28%, proteinuria in 10.93%, acute kidney injury (AKI) in 10.81% and AKI and NS in 8.93%. Membranous nephropathy (MN) was the most frequent diagnosis (28.79%), followed by diabetic nephropathy (DN, 9.75%), IgA nephropathy (IgAN, 9.64%) and vasculitis (6.82%). When compared with the control group, the results showed that MN (P < 0.0001), DN (P < 0.0001), vasculitis (P < 0.0001) and amyloidosis (P < 0.0001) occurred more frequently and IgAN (P < 0.0001), lupus nephritis (P < 0.0001) and minimal change disease (P < 0.0001) occurred less frequently in the elderly. Conclusion. This study is the first and largest renal biopsy series to analyze patients aged ≥65 years in China, and the results obtained from this study may increase the knowledge of renal diseases in elderly patients.
I N T R O D U C T I O N
As the population increases, aging has gradually become a prominent public health problem worldwide. From 2000 to 2030, the percentage of the population aged ≥65 years is projected to increase from 6.9 to 12.0% worldwide [1] . China is also confronting the problem of population aging. The segment with the fastest growth rate comprises individuals aged ≥65 years, with an expected increase from 8.3% of the population in 2008 to 16 .23% of the population by 2030 [2] .
As life expectancy increases, more elderly patients are surviving longer with acute and chronic diseases. The incidence and prevalence of chronic kidney disease (CKD) and endstage renal disease (ESRD) exhibit an increasing trend similar to those of other diseases [3] [4] [5] . Compared with the CKD prevalence in patients aged 20-39 years, which was only 0.7%, the proportion was up to 37.8% in patients older than 70 years [3] . In an observational study of 1299 native inhabitants in Shanghai, China, Yang et al. [6] found that 9.2% of the subjects were ≥65 years of age and had Stages 3 through 5 CKD. In addition, age appears to significantly modify the prognosis of kidney diseases. O'Hare et al. [4] reported that 28% of patients aged ≥75 years with Stages 3 through 5 CKD develop ESRD.
The elderly are affected by the same types of kidney diseases as the adult population; however, specific pathogenetic mechanisms contribute to the development of kidney diseases, such as the gradual structural loss and functional decline during aging, those involved in the course of cardiovascular or other systemic diseases, potential nephrotoxic drug effects and surgical treatment performance. Renal biopsy provides important diagnostic information in elderly patients. Several studies have analyzed renal diseases in elderly and very elderly patients from Europe, the USA and Asia [7] [8] [9] [10] [11] . However, such studies are few in number, with limited cohorts of patients with biopsy-proven renal diseases in China [12, 13] .
The present investigation aimed to examine the spectrum of biopsy-proven renal diseases and their respective clinical manifestations in a large group of Chinese elderly patients aged ≥65 years.
M AT E R I A L S A N D M E T H O D S
All native renal biopsies from patients aged ≥65 years were collected from January 2003 to December 2012 at the National Clinical Research Center of Kidney Disease, Jingling Hospital (Nanjing, China). The indications for the renal biopsies included proteinuria (>0.4 g/24 h) and/or hematuria (urine sediment red cell count >100 000/mL) and/or decreased kidney function, with or without coexisting systemic disease. All biopsy specimens were prepared and examined by the same group of clinicians and pathologists. The kidney biopsy specimens were divided and processed for light microscopy, immunohistology and electron microscopy. Light microscopic examinations of sections (2 μm) stained with hematoxylin and eosin, Masson's trichrome, periodic acid-Schiff and periodic acid-silver methenamine were performed. Cryosections (4 μm) were stained with fluorescein isothiocyanate-conjugated rabbit anti-human immunoglobulin G (IgG), IgA, IgM, complement 3 (C3), C4 and C1q. Paraffin sections were stained with fibrinogen. Anti-κ and -λ chain staining were routinely performed on samples from patients aged ≥50 or <50 years with suspected amyloidosis or light-chain deposition disease (e.g. patients with elevated serum κ or λ chain levels or with abnormal ratio of serum and urine κ/λ or dysproteinemia). Congo red staining was performed on samples from patients with suspected amyloidosis or the condition described previously. The clinical manifestations were defined and classified as follows.
Nephrotic syndrome (NS): NS was defined as proteinuria ≥3.5 g/24 h and serum albumin ≤30 g/L, without acute kidney injury (AKI) or chronic renal failure (CRF) and with or without hematuria. Proteinuria (without NS): patients with proteinuria <3.5 g/24 h or proteinuria ≥3.5 g/24 h without hypoalbuminemia (serum albumin ≤30 g/L) were included in this group. Note that the patients in this group had no significant decline in renal function and no hematuria. Proteinuria and hematuria: the clinical presentation in this group was defined as proteinuria, as described previously, plus the presence of hematuria without a significant decline in renal function. Hematuria: hematuria was defined as the presence of hematuria without proteinuria and without a significant decline in renal function. AKI: AKI was defined as a rapid deterioration in the glomerular filtration rate (GFR), with or without oligoanuria or rapidly progressive renal failure, including worsening of CKD; patients with both AKI and NS, as defined below, were classified separately as 'AKI and NS'. AKI and NS: patients with AKI and NS were classified into this group. CRF: CRF was defined as an estimated GFR (eGFR) that was persistently <60 mL/min/1.73 m 2 for >3 months. The Modification of Diet in Renal Disease formula was used to determine the eGFR. Other: patients were included in this group if their clinical presentation did not match any of those described previously.
Furthermore, the classification of renal disease mainly followed the methods of Li and Liu [14] and Okpechi et al. [15] (see 'Methods' in [15] ). Renal diseases were divided into five groups: primary glomerular disease, secondary glomerular disease, tubulointerstitial disease, coincidence of two glomerular diseases and unclassified. Renal biopsies with two concurrent glomerular diseases were defined as 'coincidence of two glomerular diseases', and the individual glomerular disease in this class was not recounted as the primary or secondary glomerular disease. However, some renal biopsies have severe tubulointerstitial lesions that are inconsistent with glomerular injury; to categorize these cases mainly according to the histopathological diagnosis of glomerular disease, the concurrent tubulointerstitial lesions were not recounted in 'tubulointerstitial disease' and are listed in a separate table.
To identify the presence of renal biopsy-related complications, the clinical record of each elderly patient was carefully reviewed and the severity of complications was categorized as minor (those resulting in perirenal hematoma and/or hematuria resolved spontaneously) or major (those resulting in the need for blood transfusion indicated by a decrease of hemoglobin level >40 g/L, a higher level of care or vasopressors to maintain hemodynamic stability, or the need for angiographic or surgical interventions or death). To determine whether the incidence of major complications was high in elderly patients, the incidence was compared with that of a group of 3948 patients, 18-64 years old, who underwent renal biopsy in 2011.
To increase the intuitive nature of the epidemiologic characteristics of renal diseases in the elderly patients from our unit, the data were also compared with those of a control group of 28 574 patients aged 18-64 years over the same period. We also compared our data with studies from different countries.
Statistical analyses
Values are expressed as the number of cases and percentages. The χ 2 -test and Fisher's exact test were used to analyze the categorical data, with the SPSS 18.0 software for Windows (SPSS Inc., Chicago, IL). A P-value of <0.05 was considered to be statistically significant.
R E S U LT S
Of the 29 425 native renal biopsy specimens, 2.89% were performed in patients aged ≥65 years. These 851 patients included 549 males and 302 females (ratio 1.82 : 1; mean age 69.2; range, 65-81 years). Figure 1 shows the number of patients distributed by age and gender.
The biopsy-proven spectrum in elderly patients is shown in Table 1 . The overall ratio of primary to secondary glomerular diseases was 1.52 : 1 (459-302). Of the primary glomerular diseases suffered by the elderly patients, membranous nephropathy (MN) was the most frequent histological type, followed by IgA nephropathy (IgAN) and minimal change disease (MCD). Of the secondary glomerular disease, the most common diagnosis was diabetic nephropathy (DN), followed by vasculitis and AL-amyloidosis. The most common diagnosis in tubulointerstitial disease was acute interstitial nephritis (AIN), followed by chronic interstitial nephritis (CIN) and acute tubular necrosis (ATN).
The patients' clinical manifestations are shown in Figure 2 . The most common clinical manifestations were NS, followed by CRF, proteinuria and hematuria, proteinuria, AKI and AKI and NS.
As shown in Table 2 , MN was the leading cause of NS, proteinuria and proteinuria accompanied hematuria. The most common cause of CRF was DN, followed by IgAN and MN. The most common of cause of AKI was vasculitis, followed by AIN and ATN. The most common cause of NS accompanied AKI was focal segmental glomerulosclerosis (FSGS), followed by MCD and MN. IgA was the leading cause of hematuria. The frequency of biopsy-proven renal disease subdivided by the daily proteinuria levels is shown in Supplementary data, Table S3 . As shown in Figure 3 , the patients with MN and amyloidosis most frequently developed NS, whereas the patients diagnosed with DN presented with CRF. The most common manifestation for patients with IgAN who underwent renal biopsy was CRF, whereas proteinuria accompanied by hematuria was the second most common manifestation. Patients with vasculitis mainly presented with AKI and CRF. Approximately half of the patients with FSGS most frequently developed NS accompanied by AKI, whereas patients with MCD presented with NS, with or without AKI. The histopathologic data of the 851 elderly patients were compared with those of the 28 574 patients aged 18-64 years (mean age, 37.0 ± 12.0 years) undergoing renal biopsy within the same time period. MN, DN, vasculitis and amyloidosis were significantly more prevalent in the elderly patients, but IgAN, lupus nephritis (LN) and MCD were significantly less prevalent in elderly patients than in the control group (P < 0.0001, Figure 4) . When comparing the histopathologic data of the 73 patients aged ≥75 years (very elderly) with those of the 778 patients aged 65-74 years, DN and FSGS were less frequent in very elderly patients (P = 0.037 and 0.041, respectively), but MN was more frequent compared with patients aged 65-74 years (P = 0.01, Supplementary data, Figure S1 ).
As shown in Table 3 , 29 patients (3.41%) had two coincident glomerular diseases. Most of these diseases fell under the characteristics of MN, DN or IgAN. Fifty-one patients (5.99%) with coincidence of glomerular disease and tubulointerstitial disease are shown in Table 4 .
Renal biopsy-related complications in the elderly are shown in Table 5 . Of these 48 cases, minor bleeding complications occurred in 43 cases (5.05%). Major complications occurred in five patients (0.59%), who required a blood transfusion; no other invasive intervention procedures were required, and no patients died because of the renal biopsies. The incidence of major complications in 3948 patients aged 18-64 years was 0.2% (8 of 3498), including six cases of gross hematuria and two cases of hematoma. In these eight patients, blood transfusion was needed in seven cases, and radiologic embolization and blood transfusion were needed in one case. No other complications, such as acute renal obstruction or failure, septicemia or death, occurred in these two groups of patients. There was no difference in the incidence of major complications between these two age groups (P = 0.064).
The anti-neutrophil cytoplasmic antibody (ANCA) serology and pulmonary infiltration in patients with vasculitis are listed in Table 6 . No patients had an additional diagnosis of anti-glomerular basement membrane nephritis (anti-GBM nephritis).
F I G U R E 1 : Age and gender distribution of the elderly patients who underwent renal biopsy.
O R I G I N A L A R T I C L E
K i d n e y d i s e a s e s i n e l d e r l y C h i n e s e p a t i e n t s
D I S C U S S I O N
To the best of our knowledge, this study is the largest renal biopsy series and the first to analyze patients aged ≥65 years in China. Our center is located in eastern China. Each year, ∼280 000 outpatients and 7000 inpatients are referred to our center from across China; thus, the data might be viewed as illustrating the epidemiology of renal disease in China.
In our study, biopsies in the elderly accounted for 2.89% of all biopsies. This percentage is far lower than the 17-27.4% in other reports [7, 16] . The percentage of the population aged ≥65 years in China is 8.3% [2] , which is lower than the 14-23% reported for entire population of developed countries [17] . Another likely reason is that health insurance coverage had been low in elderly patients, although this situation is improving now. In contrast, some elderly patients were reluctant to undergo renal biopsy because of the fear of complications. In previous reports with patients aged ≥65 years, men significantly outnumbered women among the patients who received renal biopsies [7, 11, 18] , which aligned with the male predominance in our study.
MN was present in 53.38% of the primary glomerular disease cases and in 28.79% of the total elderly patients, which was significantly higher than the 10.61% in the control group (Figure 4 ). This result was comparable with several studies reporting that MN was the most common kidney disease in the elderly [7, 8, 10, 11, 18, 19] . In China, Zeng et al. [20] also reported that MN tends to occur more frequently in Chinese elderly patients. DN was the second most common cause of renal disease in the elderly and was the most frequent diagnosis in secondary glomerular diseases, which was significantly more prevalent than in the control group. The main reason for this finding is that the prevalence of diabetes increases with age and that kidney disease secondary to diabetes has an increased prevalence in older people [21] . Nonetheless, the percentage of DN in our elderly patients (9.75% of all elderly) was slightly greater than that in Japan (7.7%) [11] , Ireland (6.4%) [7] and the USA (7.22%) [18] (Supplementary data, Table S2 ). The relatively higher frequency of DN in our study might be attributed to the different indications for renal biopsy in 
F I G U R E 2 :
Clinical manifestations for renal biopsy in the elderly. NS, nephrotic syndrome; CRF, chronic renal failure; AKI, acute kidney injury. 
O R I G I N A L A R T I C L E
elderly diabetics. In Western countries, a biopsy is typically performed for diabetes when urinary abnormalities or renal functions are inconsistent with either the clinical manifestations or the natural history of DN [22] . In contrast, we performed renal biopsies in diabetic patients who had renal involvement without severe biopsy contraindications [23] . These different indications for renal biopsy in diabetics also account for why the prevalence of nondiabetic renal disease superimposed on DN was lower in our patients (26 of 107, 24.30%) than that reported by previous studies (45-57%) [24] [25] [26] [27] . As reported by previous studies, IgAN is the most common CKD in China and is mainly diagnosed between the 20 and 40 years of life [14, [28] [29] [30] . Our finding was consistent with the characteristics of age distribution; the incidence of IgAN was less frequent in the elderly than in the control group. This finding was also comparable with other studies in elderly patients [9-11, 16, 18, 31] . Consistent with other reports [9-11, 16, 18, 31-35], vasculitis and amyloidosis were common, and LN and MCD were less frequent in our elderly patients. We also observed the spectrum of kidney disease in our very elderly patients (aged ≥75 years) and found a higher incidence of MN and a lower incidence of DN and FSGS in this group compared with the patients aged 65-74 years (Supplementary data, Figure S1 ). These results reflect the different clinical context in our very elderly patients. However, MN occurred with greatest frequency in our very elderly patients, which was inconsistent with previous studies of patients aged ≥80 years in Western countries, which reported that pauciimmune glomerulonephritis (GN) was the most common diagnosis in the very elderly group [7, 8, 18] . The proportion of tubulointerstitial disease (5.41%) in our patients was low, because the diagnosis of tubulointerstitial disease is mainly based on clinical evidence and other noninvasive measure other than renal biopsy. However, we also found some patients (5.99%) with tubulointerstitial disease superimposed on the glomerular disease, particularly for those with nephrotic-range proteinuria (Table 4) . Although the exact cause was difficult to identify, several conditions could be associated with the development of tubulointerstitial lesion in patients with glomerular disease, including structural and functional changes in the aging kidney, decreased rate of drug clearance and heighted sensitivity to drug toxicity, proximate tubular injury and interstitial damage induced by proteinuria overload and complicated infection [21, 36] .
In our study, NS was the most common clinical manifestation for renal biopsy, and MN was the most common pathologic diagnosis in NS, followed by amyloidosis and MCD, which was similar to previous studies [10, 11, 16, 19, 37] (Figure 2 ; Tables 2 and 3; Supplementary data, Tables S1 and  S2 ). Zhou et al. [35] reported that the incidence of amyloidosis increased in parallel with patient age and that renal amyloidosis accounted for approximately one-tenth of patients with NS. These findings are consistent with our results, in which amyloidosis accounted for 9.84% of our elderly patients with NS, thereby emphasizing the fact that renal biopsy should be performed in elderly NS patients because of the different treatments for primary NS. However, some studies have also reported that AKI (which includes acute nephritic syndrome and rapidly progressive glomerular nephritis) is the most frequent indication for renal biopsy in the elderly [4, 7] . Compared with these studies, AKI was the fourth most common indication for renal biopsy in our study. The significantly greater incidence of AKI in these developed countries than in our results may have some likely explanations. First, elderly patients in developed countries may be more frequently subjected to invasive procedures and exposed to multiple medications and radiocontrast agents [32] . Second, in most studies of elderly patients, pauci-immune GN associated with vasculitis is the main cause of the acute deterioration of their renal function. In our study, vasculitis was the main histopathological The percentages represent the incidence of complications in all 851 elderly patients. Patients with coincidence of two glomerular diseases were included. ANCA, anti-neutrophil cytoplasmic antibody; P, perinuclear; MPO, myeloperoxidase; C, cytoplasmic; PR3, proteinase 3.
K i d n e y d i s e a s e s i n e l d e r l y C h i n e s e p a t i e n t s type in AKI (accounting for 33.7%), but it only accounted for 6.82% of all biopsies performed. In contrast, in many other countries, this percentage was closer to 12.97-39% of all patients [7, 8, 18] , a rate that is far more frequent than that in our results. Notably, AKI was common in the elderly patients with NS. Smith and Hayslett [38] reported that older age is a risk factor for AKI in NS patients. In our study, 8.93% of the elderly patients presented with AKI and NS; this frequency was similar to that reported by Moutzouris et al. [8] and Omokawa et al. [34] for patients over 80 years of age (Supplementary data, Table S1 ). The reasons underlying this propensity for AKI with NS in elderly patients are not well understood. The risk of developing tubulointerstitial disease in elderly patients with NS could be one reason (as mentioned previously); however, previous studies have also reported that in some patients with NS, the etiologic factor of AKI could not be identified, and the AKI that developed in these patients was considered to be idiopathic [39] . Some authors have stated that most elderly patients with AKI associated with NS have MCD [8, 34] and that the elderly with MCD are prone to developing ATN concomitantly with the onset of NS [32, 38, [40] [41] [42] [43] . However, we found that FSGS was the most frequent disease in elderly patients with AKI associated with NS, followed by MCD. In our patients, there was a higher incidence of ATN or AIN in patients with FSGS (Table 4) . Consistent with our results, Tang et al. [36] reported the occurrence of AKI in 54.4% of FSGS presenting as NS, and acute tubulointerstitial injury is the most common cause of the development of AKI in these patients. However, the relatively high incidence of FSGS and low incidence of MCD in our elderly patients could be another reason (Supplementary data, Table S2 ).
As mentioned previously, vasculitis was the main cause of AKI in the elderly patients in this study. However, we also found vasculitis in 12.5% of the patients presenting with CRF (Table 2) , which was comparable with previous studies by Moutzouris et al. [8] and Ferro et al. [37] . In the elderly, vasculitis is the most frequent disease found with pulmonary involvement [33] . In our series, pulmonary infiltrates were observed in 60% (36 of 60) of the patients (Table 6) , which were far more frequent than those reported by two other groups (29 and 29.3%) [8, 32] .
Previous studies have reported that the incidence of renal biopsy-related complication in the elderly is 7-8%, which is similar to that in the general adult population; serious adverse effects requiring surgical intervention occur in <1% and the mortality rate is <0.1% [44] [45] [46] . Consistent with these reports, bleeding complications occurred in 5.64% our elderly patients, and the incidence of major bleeding complications requiring a blood transfusion was 0.59%. Although the incidence of major complications in elderly patients was relatively higher than that in patients aged 18-64 years, this difference did not reach the level of statistical significance (0.59 versus 0.2%, P = 0.064). Thus, our results suggest that renal biopsy is a relatively safe procedure in elderly patients. In this study, we performed renal biopsy in elderly patients with stable biopsy and diagnostic criteria during these 10 years. However, as a respective study, selection bias is a limitation in this study: first, the patients were not from the population screened for routine urinalysis. Second, some elderly patients were reluctant to undergo renal biopsy because of no health insurance or the fear of biopsy-related complications. Another limitation is that this study did not include treatment and outcome of the elderly patients who underwent renal biopsy.
In conclusion, primary glomerular disease was the most common renal disease in elderly patients in China. MN was the most common diagnosis in primary renal disease. NS is the major clinical presentation of renal biopsy in the elderly. MN was the main diagnosis in NS, followed by MCD and amyloidosis. There were significant differences in the spectrum of kidney diseases between the elderly and the control group. It is important that this is the first and largest renal biopsy series to analyze patients aged ≥65 years in China; therefore, the results obtained from this study may be a valuable addition to previous studies of renal diseases in elderly patients.
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